The chart below shows how IQV performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IQV sees a -1.55% change in stock price 10 days leading up to the earnings, and a +1.42% change 10 days following the report. On the earnings day itself, the stock moves by +1.38%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Strong Revenue Growth: Revenue growth of 5.5% at constant currency for the full year 2024, excluding COVID-related work, demonstrating strong operational performance.
Adjusted EBITDA Growth: Adjusted EBITDA increased by 3.1% in Q4, contributing to a full year adjusted EBITDA growth of 3.2%, reflecting effective cost management and revenue growth.
Record Free Cash Flow: Free cash flow reached a record $721 million in Q4, contributing to a total of $2.1 billion for the full year, marking a 41% increase year-over-year.
Strong Q4 Net New Bookings: Net new bookings for Q4 exceeded $2.5 billion, highlighting the successful efforts of the RMBS team in securing new business contracts despite a challenging environment.
Backlog Growth and Demand: The backlog at year-end stood at $31.1 billion, representing a 5.5% increase year-over-year at constant currency, indicating strong demand and future revenue visibility.
Negative
Quarterly Revenue Growth Slowdown: Revenue for the fourth quarter grew only 2.3% on a reported basis and 3% at constant currency, indicating a slowdown in growth compared to previous periods.
R&D Revenue Decline: R&D Solutions revenue for the fourth quarter declined by 1.3% reported and 1% at constant currency, highlighting challenges in this segment.
Revenue Decline in Medical Solutions: Contract Sales and Medical Solutions revenue decreased by 4.8% reported and 3.2% at constant currency, reflecting ongoing difficulties in this area.
Increased Cancellations and Volatility: Cancellations in 2024 were nearly 50% higher than the average of the previous three years, indicating increased volatility and uncertainty in client spending.
Bookings Performance Analysis: Gross new bookings before cancellations were up mid single digits, but the elevated cancellations led to a challenging net bookings environment.
Earnings call transcript: IQVIA Q4 2024 beats expectations, stock rises
IQV.N
-2.15%